Disc Medicine annual operating income
2020
2021
2022
2023
2024
2025
Disc Medicine Operating Income Growth & History (IRON)
Disc Medicine's operating income was −$236.0M for fiscal 2025.
View full Disc Medicine company overviewDisc Medicine annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$236.0M | −$106.3M | — |
| 2024 | 2024-12-31 | −$129.7M | −$38.6M | — |
| 2023 | 2023-12-31 | −$91.1M | −$43.6M | — |
| 2022 | 2022-12-31 | −$47.5M | −$16.5M | — |
| 2021 | 2021-12-31 | −$30.9M | $3.1M | — |
| 2020 | 2020-12-31 | −$34.0M | — | — |
Disc Medicine quarterly operating income
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$65.1M | −$3.7M | — |
| Q1 2026 | 2026-03-31 | −$69.5M | −$29.6M | — |
| Q4 2025 | 2025-12-31 | −$67.0M | −$32.4M | — |
| Q3 2025 | 2025-09-30 | −$67.7M | −$34.8M | — |
| Q2 2025 | 2025-06-30 | −$61.4M | −$30.6M | — |
| Q1 2025 | 2025-03-31 | −$39.9M | −$8.5M | — |
| Q4 2024 | 2024-12-31 | −$34.5M | −$4.8M | — |
| Q3 2024 | 2024-09-30 | −$32.9M | −$13.9M | — |
| Q2 2024 | 2024-06-30 | −$30.9M | −$13.5M | — |
| Q1 2024 | 2024-03-31 | −$31.5M | −$6.3M | — |
| Q4 2023 | 2023-12-31 | −$29.7M | −$14.7M | — |
| Q3 2023 | 2023-09-30 | −$19.0M | −$8.5M | — |
| Q2 2023 | 2023-06-30 | −$17.3M | −$5.3M | — |
| Q1 2023 | 2023-03-31 | −$25.1M | −$15.2M | — |
| Q4 2022 | 2022-12-31 | −$15.0M | −$35.3M | — |
| Q3 2022 | 2022-09-30 | −$10.5M | $8.0M | — |
| Q2 2022 | 2022-06-30 | −$12.0M | $4.3M | — |
| Q1 2022 | 2022-03-31 | −$10.0M | $6.5M | — |
| Q4 2021 | 2021-12-31 | $20.3M | $30.1M | — |
| Q3 2021 | 2021-09-30 | −$18.4M | −$10.5M | — |
| Q2 2021 | 2021-06-30 | −$16.3M | −$9.7M | — |
| Q1 2021 | 2021-03-31 | −$16.5M | −$6.9M | — |
| Q4 2020 | 2020-12-31 | −$9.8M | — | — |
| Q3 2020 | 2020-09-30 | −$7.9M | — | — |
| Q2 2020 | 2020-06-30 | −$6.7M | — | — |
| Q1 2020 | 2020-03-31 | −$9.6M | — | — |
Disc Medicine operating income trends
Over the last five fiscal years, Disc Medicine's operating income decreased from −$34.0M to −$236.0M, a change of −$202.0M. The latest reported quarter, Q2 2026, shows −$65.1M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Disc Medicine source filings ↗Community posts
Disc Medicine prices an enlarged $450 million equity offering
Disc Medicine ($IRON) priced an upsized public offering of six million common shares at $75 each, generating expected gross proceeds of $450 million before underwriting discounts and expenses. Underwriters have a 30-day option to buy anothe ...
